Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with ...

RBC表示，如果EDG-7500在单次递增剂量(SAD)试验中的数据显示出在梯度降低上有所改善，同时也显示出功能改善(如用于评估心力衰竭(HF)患者症状、功能和生活质量受影响程度的KCCQ评分)，并且二四六天天彩资料大全网有证据表明该疗法在非梗阻性HCM(nHCM)中起作用 ...

Cardiac myosin inhibitors were recently developed to address the underlying pathophysiology of hypertrophic cardiomyopathy and to improve symptoms and quality of life. In this review, we evaluated the ...